Elekta Unveils Multiple Innovative Technologies at CIIE, Propelling Precision Radiotherapy to New Heights

Elekta Unveils Multiple Innovative Technologies at CIIE, Propelling Precision Radiotherapy to New HeightsThe 7th China International Import Expo (CIIE) opened in Shanghai on November 5th. Elekta, a global leader in the field of precision radiotherapy, showcased its presence for the seventh consecutive year at the expo, themed Global Pioneer in Precision Radiotherapy, Empowering High-Quality Radiotherapy Development, and introduced several groundbreaking innovative technologies

Elekta Unveils Multiple Innovative Technologies at CIIE, Propelling Precision Radiotherapy to New Heights

The 7th China International Import Expo (CIIE) opened in Shanghai on November 5th. Elekta, a global leader in the field of precision radiotherapy, showcased its presence for the seventh consecutive year at the expo, themed Global Pioneer in Precision Radiotherapy, Empowering High-Quality Radiotherapy Development, and introduced several groundbreaking innovative technologies.

At this year's CIIE, Elekta unveiled the Elekta Evo, an intelligent, adaptive, and integrated radiotherapy platform, for the first time in Asia. This platform, driven by a one-stop comprehensive solution, empowers clinicians to flexibly address a wide range of indications, enabling them to tailor personalized treatment plans for each patient. A highlight of the Elekta Evo platform lies in its integration of Iris HD AI-enhanced imaging technology, which provides high-resolution, true-to-life images, offering deep insights into lesions and meeting both routine and specialized clinical needs.

Furthermore, Elekta premiered the Elekta ONE intelligent radiotherapy platform in China. This highly integrated software solution consolidates Elekta's best innovations and solutions for oncology software, resulting in faster innovation, a smoother user experience, and a unified user interface. The streamlined, intelligent, and data-driven processes of the Elekta ONE platform empower clinicians to effortlessly employ various cancer treatment modalities, significantly enhancing patient treatment outcomes.

It is noteworthy that Elekta Unity 3.0, the company's latest high-field magnetic resonance radiotherapy system, also made its Asia-Pacific debut at the CIIE. This system, powered by three groundbreaking innovations, elevates precision radiotherapy to a new level:

• High-field magnetic resonance-guided adaptive radiotherapy technology: Enables ultra-fast and ultra-clear image guidance during treatment, improving therapeutic precision.

• Biologically guided adaptive radiotherapy technology: Real-time monitoring of biological changes in tumors during treatment, allowing earlier guidance and intervention in treatment plan adjustments, enhancing efficacy.

• Comprehensive motion management solution: Unlocks the real-world understanding of tumor motion during treatment for the first time, achieving automatic gated precise irradiation and minimizing treatment errors caused by tumor movement.

Beyond these debuting technologies, Elekta's booth also featured dedicated zones for close-range treatment solutions and neuroscience solutions, showcasing its expertise and innovative technologies in treating tumors such as cervical cancer and breast cancer.

Gustaf Salford, Elekta's Global President and CEO, stated, "As a long-standing and trusted partner in China's radiotherapy sector, Elekta anticipates that the implementation of these innovative technologies in the Chinese market will benefit countless patients. Simultaneously, we hope that the experience and case studies from China's domestic market will serve as valuable Chinese wisdom that can be leveraged and shared globally through Elekta's global presence, further driving improvements in radiotherapy standards worldwide."

Elekta's exhibition of these groundbreaking innovative technologies at the CIIE not only reflects its leading position in precision radiotherapy but also demonstrates its commitment to the Chinese market and its determination to drive advancements in China's radiotherapy technology. Looking ahead, Elekta is poised to continue empowering the high-quality development of China's radiotherapy sector with its innovative technologies and services, bringing hope to countless patients.

Disclaimer: The content of this article is sourced from the internet. The copyright of the text, images, and other materials belongs to the original author. The platform reprints the materials for the purpose of conveying more information. The content of the article is for reference and learning only, and should not be used for commercial purposes. If it infringes on your legitimate rights and interests, please contact us promptly and we will handle it as soon as possible! We respect copyright and are committed to protecting it. Thank you for sharing.(Email:[email protected])